Welcome to our dedicated page for The Oncology Institute Warrant news (Ticker: TOIIW), a resource for investors and traders seeking the latest updates and insights on The Oncology Institute Warrant stock.
The Oncology Institute of Hope and Innovation is a premier cancer treatment center in Los Angeles, offering comprehensive programs to support patients and families dealing with cancer. Their dedicated team provides personalized treatment plans and services across 8 locations in Southern California.
The Oncology Institute Inc focuses on cancer prevention, diagnosis, treatment, research, and education. Services include infusion centers, in-house dispensary, outpatient transfusions, stem cell transplants, financial counseling, clinical trials, lab testing, and end-of-life support. The company operates in three segments: dispensary, patient services, and clinical trials.
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) disclosed that Dr. Daniel Virnich, TOI’s CEO, will join the 'Defining the Next Chapter in Value-Based Care' panel at the Leerink Healthcare Transformation Summit on May 16, 2024. TOI is a leading value-based oncology practice in the U.S.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.96%
Tags
-
Rhea-AI Summary
The Oncology Institute, (“TOI”) announces the release of its first quarter 2024 financial results on May 14, 2024, followed by a conference call at 5:00 p.m. (Eastern Time). Interested parties can access the live conference call and replay by phone or webcast. TOI is a leading value-based oncology group in the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) appoints Jordan McInerney as the new Chief Development Officer, bringing over 15 years of healthcare leadership experience. McInerney will focus on growth initiatives, partnerships with payors, M&A processes, and establishing MSO platforms for value-based oncology care. His background includes executive roles at HOPCo Network Solutions and Stryker, emphasizing value-based care solutions and strategic partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6%
Tags
Rhea-AI Summary
The Oncology Institute, Inc. (TOI) partners with Healthly to provide cancer care services in Southern California, starting July 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) reported financial results for Q4 2023, showing revenue growth, a capitated contract in South Florida, and an acquisition. Despite revenue growth, there was a decrease in gross profit and a net loss. TOI's CEO is optimistic about future success, with an outlook for 2024 projecting revenue of $400-415 million and adjusted EBITDA of $(8)-$(18) million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.13%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) announces a new agreement with MaxHealth for clinical and financial accountability in 5 Florida Counties. TOI will take on full-risk responsibility for oncology care in Pinellas, Hillsborough, Polk, Broward, and Miami-Dade Counties, aligning with MaxHealth's value-based care model. The partnership aims to provide exceptional cancer care to patients through a focus on outcomes, quality, and community-based oncology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.62%
Tags
Rhea-AI Summary
The Oncology Institute (TOI) will release its Q4 and full year 2023 financial results on March 27, 2024. The conference call will be held at 5:00 p.m. (Eastern Time) on the same day. Investors can access the call via phone or webcast. Replay options are available until April 3, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
-
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) announces Dr. Daniel Virnich's participation in upcoming investor conferences. Investors can join webcasts to hear insights at Cowen Annual Health Care Conference and Jefferies Value Based Healthcare Summit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
-
Rhea-AI Summary
The Oncology Institute (TOI) partners with Carrum Health to offer high-quality, cost-effective breast cancer care in Las Vegas, Nevada. The collaboration aims to provide comprehensive bundled packages for non-metastatic breast cancer patients through employers, expanding TOI's patient base and network access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
Rhea-AI Summary
WellBe Senior Medical strengthens its cancer care capabilities by partnering with The Oncology Institute, Inc. (NASDAQ: TOI) to offer High-Value Cancer Care Program to eligible patients in Illinois and Ohio. The program aims to provide personalized care management and supportive services to patients with active cancer diagnoses, resulting in improved patient satisfaction and reduced acute care facility utilization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
FAQ
What is the current stock price of The Oncology Institute Warrant (TOIIW)?
The current stock price of The Oncology Institute Warrant (TOIIW) is $0.0165 as of November 4, 2024.
What services does The Oncology Institute provide?
The Oncology Institute offers a range of services including infusion centers, in-house dispensary, outpatient transfusions, stem cell transplants, financial counseling, clinical trials, lab testing, and end-of-life support.
How many locations does The Oncology Institute have in Southern California?
The Oncology Institute has 8 locations across Southern California, including cities like Downey, Long Beach, Anaheim, and Glendale.
What are the key revenue drivers for The Oncology Institute?
The key revenue for The Oncology Institute comes from providing patient services, including cancer prevention, diagnosis, treatment, and research.
What is the mission of Healthly in collaboration with The Oncology Institute?
The mission of Healthly is to revolutionize healthcare by empowering doctors to provide comprehensive care to patients. Together with The Oncology Institute, they aim to deliver innovative cancer care services in Southern California.
Who is the CEO of The Oncology Institute?
Dr. Daniel Virnich is the CEO of The Oncology Institute, leading the organization in providing specialized cancer care services to patients.
How is The Oncology Institute changing oncology for the better?
The Oncology Institute is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, with a focus on evidence-based treatment and patient outcomes.
The Oncology Institute, Inc. Warrant
Nasdaq:TOIIW
TOIIW Rankings
TOIIW Stock Data
75.49M
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
United States of America
CERRITOS